Skip to main content
Skip to section navigation
Skip to footer
About
Our Science
Therapeutic Areas
Platform
Partnering
Pipeline
Careers
Media & Resources
Investors
Contact
Contact
Press Releases
Investors
Investors
Overview
Company Info
Executive Team
Presentations
Contacts
FAQ
News & Events
Press Releases
IR Calendar
Email Alerts
Financials
Stock Data
Historical Data
Analyst Coverage
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Current Reports
Annual Shareholder Reports
Corporate Governance
Board of Directors
Board Committees
Governance Documents
Year
All Years
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Category
All Releases
Financial Releases
Feb 26, 2024 7:45 am EST
iBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to Otsuka
Jan 16, 2024 8:15 am EST
iBio Announces Participation in 23rd Annual PepTalk Conference
Previous Page
arrow_back
Page
1
Page
2
Select a page
Page 1
Page 2
rss_feed
News RSS
email
Email Alerts
location_city
Company Profile
contact_page
Contacts
rss_feed
RSS News Feed